Publication:
A phase 2 trial of HQK-1001 in HbE-β thalassemia demonstrates HbF induction and reduced anemia

Simple item page
dc.contributor.authorPoramin Patthamalaien_US
dc.contributor.authorSuthat Fuchareonen_US
dc.contributor.authorNattawara Chaneiamen_US
dc.contributor.authorRichard G. Ghalieen_US
dc.contributor.authorDavid H.K. Chuien_US
dc.contributor.authorMichael S. Boosalisen_US
dc.contributor.authorSusan P. Perrineen_US
dc.contributor.otherMahidol Universityen_US
dc.contributor.otherHemaQuest Pharmaceuticalsen_US
dc.contributor.otherBoston University School of Medicineen_US
dc.date.accessioned2018-11-09T01:53:38Z
dc.date.available2018-11-09T01:53:38Z
dc.date.issued2014-03-20en_US
dc.identifier.citationBlood. Vol.123, No.12 (2014), 1956-1957en_US
dc.identifier.doi10.1182/blood-2013-11-538470en_US
dc.identifier.issn15280020en_US
dc.identifier.issn00064971en_US
dc.identifier.other2-s2.0-84897487469en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/123456789/33285
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84897487469&origin=inwarden_US
dc.subjectBiochemistry, Genetics and Molecular Biologyen_US
dc.subjectImmunology and Microbiologyen_US
dc.subjectMedicineen_US
dc.titleA phase 2 trial of HQK-1001 in HbE-β thalassemia demonstrates HbF induction and reduced anemiaen_US
dc.typeLetteren_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84897487469&origin=inwarden_US

Files

Collections

Scopus 2011-2015